Live News EQUITY FLASH L impact Oct 18, 2026, 10:40 PM UTC BioInvent to Present BI-1808 Data at ESMO 2026 BioInvent plans to present BI-1808 data in platinum-resistant recurrent ovarian cancer at ESMO 2026. BINV SquawkNews Desk